Ledger.Open graph →
SEC Form D · filed December 10, 2021

Phylos Bioscience, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Other
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Ralph J. Risch · Portland, ORExec · DirectorDavid J. Patterson · Portland, ORDirectorDylan J. Anderson · Portland, ORExecNishan Karassik · Portland, ORExec · DirectorTimothy J. Gregory · Portland, ORDirectorJeffery Sarrett · Denver, COExecDaniel Benel · Denver, CODirectorWilliam D. De Laszlo · Los Angeles, CAExec · DirectorJeffrey Manno · Charleston, SCExec · DirectorRick Schultze · Charleston, SCExecAustin R. Fitzgerald · Idaho Falls, IDDirectorNishan Karassik · Portland, ORExec · DirectorTimothy J. Gregory · Portland, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗